Table 5.

Population coverage of the selected epitope included in the vaccine construct.

Population/area	Class combined
	Coveragea	Average_hitb	pc90c
Central Africa	99.34%	26.31	14.8
East Africa	99.25%	25.78	14.64
East Asia	100.0%	39.72	28.42
Europe	100.0%	47.54	35.91
North Africa	99.8%	30.56	17.21
North America	100.0%	46.02	31.76
Northeast Asia	99.1%	24.76	14.4
Oceania	99.35%	24.71	14.5
South Africa	99.82%	28.55	15.78
South America	100.0%	31.57	21.27
South Asia	100.0%	40.36	28.65
Southeast Asia	100.0%	35.37	22.34
Southwest Asia	98.64%	23.09	14.02
West Africa	99.55%	27.53	15.21
West Indies	99.46%	24.44	14.66
World	100.0%	44.2	30.49
Average	95.83	30.82	19.71
Standard deviation	15.27	10.49	8.55

^aCoverage of population on projected.

^bPopulation recognized by HLA combinations/epitope hits on the average number.

^c90% of the population recognized by HLA combinations/epitope hits on the minimum number.